Press release - 30/06/2026 Franziska Kolb Prize for personalised leukaemia research Dr. Alexandra Niedermayer receives 8,000 euros Cancer researcher Dr Alexandra Niedermayer from the Ulm Children’s and Adolescents’ Clinic has been awarded the Franziska Kolb Prize, worth 8,000 euros, by the Ulm University Foundation. The 32-year-old researches aggressive forms of blood cancer and, using modern techniques, has identified an effective, personalised treatment approach. https://www.gesundheitsindustrie-bw.de/en/article/press-release/franziska-kolb-prize-personalised-leukaemia-research-dr-alexandra-niedermayer-receives-8000-euros
Press release - 26/06/2026 CRIION Joachim Frank Prize 2026 awarded to cancer researchers in Freiburg On Thursday, 25 June 2026, several Freiburg cancer researchers were honoured at the presentation of the CRIION Joachim Frank Prize 2026. Among them was Prof. Dr Robert Zeiser, who received the Prize for Biomedical Research. Prof. Dr Jürgen Finke, PD Dr Florian Scherer and PD Dr Elisabeth Schorb of the University Medical Center Freiburg, together with Prof. Dr Gerald Illerhaus of Stuttgart Hospital, were awarded the Prize for Clinical Medicine.https://www.gesundheitsindustrie-bw.de/en/article/press-release/criion-joachim-frank-prize-2026-awarded-cancer-researchers-freiburg
Press release - 01/07/2026 Hahn-Schickard Becomes a gGmbH – Karl-Peter Fritz Is the New Managing Director Effective July 1, the Hahn-Schickard Association for Applied Research e.V. will spin off its operational business and transfer it to the newly founded Hahn-Schickard gGmbH. This nonprofit company has assumed the universal legal succession of the association and has been entered in the commercial register of the Stuttgart District Court. It is legally represented by its managing director, Dr. Karl-Peter Fritz.https://www.gesundheitsindustrie-bw.de/en/article/press-release/hahn-schickard-becomes-ggmbh-karl-peter-fritz-new-managing-director